Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KPTI

Karyopharm Therapeutics Inc.

CIK 0001503802 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$1.96
↑ 0.14 (7.69%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Technicals

Key stats

Market Cap
$44.46M
P/E Ratio
-0.20
EPS
-17.93
Dividend Yield
Not covered
52W Position
2%
Beta
0.67

Valuation multiples

Fwd P/E
Not covered
PEG
-0.15
P/B
-0.13
P/S
0.30
EV/Revenue
-0.07
ROE
68.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 2%
$1.79$10.99

Latest Financials

2025-12-31 FY
Revenue
$146.07M
Net Income
-$196.04M
Total Assets
$108.42M
Free Cash Flow
-$75.37M

Recent news